View on Pubmed.gov 33928245 | View on doi.org 10.1093/brainco...
Quantification of N-terminal amyloid-β isoforms reveals isomers are the most abundant form of the amyloid-β peptide in sporadic Alzheimer's disease.
- Florey Institute of Neuroscience and Mental Health, University of Melbourne, Melbourne, VIC 3010, Australia.
- Department of Anatomical Pathology, Alfred Hospital, Prahran, VIC 3004, Australia.
- Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
- Department of Neurology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Abstract
Plaques that characterize Alzheimer's disease accumulate over 20 years as a result of decreased clearance of amyloid-β peptides. Such long-lived peptides are subjected to multiple post-translational modifications, in particular isomerization. Using liquid chromatography ion mobility separations mass spectrometry, we characterized the most common isomerized amyloid-β peptides present in the temporal cortex of sporadic Alzheimer's disease brains. Quantitative assessment of amyloid-β N-terminus revealed that > 80% of aspartates (Asp-1 and Asp-7) in the N-terminus was isomerized, making isomerization the most dominant post-translational modification of amyloid-β in Alzheimer's disease brain. Total amyloid-β was ∼85% isomerized at Asp-1 and/or Asp-7 residues, with only 15% unmodified amyloid-β left in Alzheimer's disease. While amyloid-β the next most abundant N-terminus found in Alzheimer's disease brain, was only ∼50% isomerized at Asp-7 in Alzheimer's disease. Further investigations into different biochemically defined amyloid-β-pools indicated a distinct pattern of accumulation of extensively isomerized amyloid-β in the insoluble fibrillar plaque and membrane-associated pools, while the extent of isomerization was lower in peripheral membrane/vesicular and soluble pools. This pattern correlated with the accumulation of aggregation-prone amyloid-β in Alzheimer's disease brains. Isomerization significantly alters the structure of the amyloid-β peptide, which not only has implications for its degradation, but also for oligomer assembly, and the binding of therapeutic antibodies that directly target the N-terminus, where these modifications are located.
References
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16742-7
Anal Chem. 2016 Aug 2;88(15):7548-55
Neuron. 2011 Sep 8;71(5):833-44
Neurology. 2019 Oct 22;93(17):e1647-e1659
Cited by 35 citations (total)
Journal Article Research Support, N.I.H., Extramural
Intermediate Antiparallel β Structure in Amyloid β Plaques Revealed by Infrared Spectroscopic Imaging.
Electronic publication date October 23, 2023
Brooke Holcombe [...] Ayanjeet Ghosh et al.
Aggregation of amyloid β (Aβ) peptides into extracellular plaques is a hallmark of the molecular pathology of Alzheimer's disease (AD)....
Journal Article Review
Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer's Disease.
Electronic publication date January 12, 2024
Sergey A Kozin [...] Vladimir A Mitkevich et al.
A hallmark of Alzheimer's disease (AD) are the proteinaceous aggregates formed by the amyloid-beta peptide (Aβ) that is deposited inside...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
Copyright
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.